Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Structure, assembly, and mechanism of the MmpL family of transporters.

Microbiology and molecular biology reviews : MMBR·2026
Same author

Essential role of MptB in the biosynthesis of phosphatidylinositol mannosides, lipomannan and lipoarabinomannan in mycobacteria.

The Journal of biological chemistry·2026
Same author

A periplasmic protein complex mediates arabinofuranosyltransferase activity and intrinsic drug resistance in <i>Mycobacterium tuberculosis</i>.

Science advances·2026
Same author

<i>Mycobacterium abscessus</i> research: learning from challenges.

Journal of bacteriology·2026
Same author

Inhibition of de novo fatty acid synthesis in Mycobacterium tuberculosis.

The Journal of biological chemistry·2025
Same author

Characterization of new mouse models of acute and chronic <i>Mycobacterium abscessus</i> infection for antimicrobial drug screening.

Antimicrobial agents and chemotherapy·2025

Related Experiment Video

Updated: May 9, 2026

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

Progress in targeting cell envelope biogenesis in Mycobacterium tuberculosis.

Mary Jackson1, Michael R McNeil, Patrick J Brennan

  • 1Mycobacteria Research Laboratories, Department of Microbiology, Immunology & Pathology, Colorado State University, Fort Collins, CO 80523-1682, USA. mary.jackson@colostate.edu

Future Microbiology
|July 12, 2013
PubMed
Summary

New tuberculosis (TB) drugs targeting the Mycobacterium tuberculosis cell envelope are effective against both active and latent TB. Research highlights novel targets beyond mycolic acid synthesis for combating drug-resistant TB.

More Related Videos

Preparation of Mycobacterium tuberculosis Culture Filtrate to Understand TB Pathogenesis
07:32

Preparation of Mycobacterium tuberculosis Culture Filtrate to Understand TB Pathogenesis

Published on: March 28, 2025

Separation and Fractionation of Cell Wall and Cell Membrane Proteins from Mycobacterium tuberculosis for Downstream Protein Analysis
06:14

Separation and Fractionation of Cell Wall and Cell Membrane Proteins from Mycobacterium tuberculosis for Downstream Protein Analysis

Published on: September 26, 2025

Related Experiment Videos

Last Updated: May 9, 2026

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

Preparation of Mycobacterium tuberculosis Culture Filtrate to Understand TB Pathogenesis
07:32

Preparation of Mycobacterium tuberculosis Culture Filtrate to Understand TB Pathogenesis

Published on: March 28, 2025

Separation and Fractionation of Cell Wall and Cell Membrane Proteins from Mycobacterium tuberculosis for Downstream Protein Analysis
06:14

Separation and Fractionation of Cell Wall and Cell Membrane Proteins from Mycobacterium tuberculosis for Downstream Protein Analysis

Published on: September 26, 2025

Area of Science:

  • Microbiology
  • Drug Discovery
  • Medicinal Chemistry

Background:

  • Tuberculosis (TB), particularly multidrug-resistant TB (MDR-TB), remains a significant global health challenge.
  • Many promising new anti-TB compounds target the unique cell envelope metabolism of Mycobacterium tuberculosis.
  • Understanding these targets is crucial for developing effective treatments.

Purpose of the Study:

  • To review the evolution of knowledge regarding Mycobacterium tuberculosis cell envelope metabolism as a target for TB drugs.
  • To highlight emerging and existing drug targets effective against both replicating and latent M. tuberculosis.
  • To discuss screening strategies for identifying new anti-TB agents.

Main Methods:

  • Literature review of scientific publications on TB drug discovery and Mycobacterium tuberculosis cell envelope.
  • Analysis of established and novel drug targets within the M. tuberculosis cell envelope.
  • Discussion of whole cell-based versus target-based screening approaches.

Main Results:

  • Numerous front-line and emerging TB drugs inhibit M. tuberculosis cell envelope metabolism.
  • These drugs demonstrate bactericidal activity against actively replicating and, contrary to previous beliefs, latent M. tuberculosis.
  • Mycolic acid and arabinogalactan synthesis remain key targets, with peptidoglycan synthesis, transport, and decaprenyl-phosphate carrier lipid synthesis showing significant promise.

Conclusions:

  • Targeting M. tuberculosis cell envelope metabolism is a highly successful strategy for developing new TB drugs.
  • Novel targets offer opportunities for new drugs, combinations, and overcoming drug resistance.
  • Both whole cell- and target-based screening are valuable for discovering new anti-TB therapies.